Merck正在招募有不受控制的克罗恩(Crohn)或超感性口炎的成年人参加实验治疗的新试验。 Merck is recruiting adults with uncontrolled Crohn’s or ulcerative colitis for new trials of an experimental treatment.

对于16至80岁的中度至重度性结肠炎或克罗恩病患者,如果他们未经先前治疗而有反应,他们可以参加两项由默克资助的临床试验,试验一种临床药物. Adults aged 16 to 80 with moderate to severe ulcerative colitis or Crohn’s disease who haven’t responded to prior treatments may qualify for two Merck-sponsored clinical trials testing an investigational medicine. 参加者必须有至少三个月的活跃性疾病,不得有其他形式的肠道炎病。 Participants must have active disease for at least three months and not have the other form of inflammatory bowel disease. 审判是自愿的,优先考虑隐私,并旨在包括不同的人群,以提高对治疗的理解。 Trials are voluntary, prioritize privacy, and aim to include diverse populations to improve treatment understanding. 更多详情请见Merck的IBD研究网站。 More details are available through Merck’s IBD Studies website.